Beijing Scitop Bio-tech (300858) Revenue Breakdown - Main Composition

17.87
+0.26+1.48%

Market Closed Jan 16 15:00 CST

4.71BMarket Cap47.40P/E (TTM)

Beijing Scitop Bio-tech (300858) Revenue Breakdown Overview

By Product

Currency:CNY

2025/H1

Stock NameRevenueRatio

食用益生菌制品116.02M71.03%

动植物微生态制剂27.71M16.96%

复配食品添加剂18.2M11.14%

益生菌技术服务1.18M0.73%

Other230.27K0.14%

By Industry

Currency:CNY

2025/H1

Stock NameRevenueRatio

Sell goods162.16M99.27%

益生菌技术服务1.18M0.73%

By Country/Region

Currency:CNY

2024/FY

Stock NameRevenueRatio

North China105.36M34.79%

East China region89.49M29.55%

Southwest area38.72M12.79%

South China30.58M10.10%

Central China16.35M5.40%

Northeast area8.8M2.91%

Northwest region7.9M2.61%

Undistributed5.61M1.85%

View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"